Management of primary biliary cirrhosis resistant to ursodeoxycholic acid therapy
- 31 December 2000
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 32, 19-20
- https://doi.org/10.1016/s0168-8278(00)80438-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trialGastroenterology, 1999
- Ten–Year Survival in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CirrhosisHepatology, 1999
- Long–Term Ursodeoxycholic Acid Delays Histological Progression in Primary Biliary CirrhosisHepatology, 1999
- Clinical Significance of Serum Bilirubin Levels Under Ursodeoxycholic Acid Therapy in Patients With Primary Biliary CirrhosisHepatology, 1999
- Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survivalPublished by Oxford University Press (OUP) ,1998
- Ursodeoxycholic Acid Delays the Onset of Esophageal Varices in Primary Biliary CirrhosisMayo Clinic Proceedings, 1997
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997